Currently, virtually every venture-funded company that went public in 2020 or 2021 is trading at a fraction of its former high. The hardest hit have largely been those who took the SPAC route to market, many of whom are now
Jay Ritter Articles: page 16
Page:
Enjoy Technology, led by ex-Apple and JC Penney executive Johnson, files bankruptcy
Insights from Cordell Eminent Scholar Jay Ritter inform this story about Enjoy Technology Inc, a Silicon Valley retailer led by former Apple Inc and JC Penney Co executive Ron Johnson, which filed for bankruptcy protection on Thursday, fewer than nine
US IPO drought to continue
Cordell Eminent Scholar Jay Ritter contributes his insights to this story about how US ECM bankers are facing the slowest market for IPOs in more than six years with few obvious signs that conditions are about to take a turn
The SPAC Era Comes to a Whimpering End
Cordell Eminent Scholar Jay Ritter contributes to this story about newly public companies getting bought out—for far less money—while blank-check promoters prepare for a more skeptical market. Read more in this story from Bloomberg.
Opinion: Delivery drones, robotaxis, even insurance — wildly hyped dreams for AI startups are giving tech investors nightmares
These are just a few examples of the reality that startups are too often funded by dreams that turn out to be nightmares. We recall Apple, Amazon.com, Google, and other grand IPO successes and forget thousands of failures. Recent data from
ANALYSIS: Time Pressure Builds on De-SPAC Deals
In 2021, Cordell Eminent Scholar Jay Ritter predicted that half of SPACs would need to return money to shareholders. After looking into what would happen if half of SPACs didn’t De-SPAC, a new Bloomberg Law analysis finds that more than
Doc’s Prescription: Many special purpose acquisition companies might go bust
Research insights from Cordell Eminent Scholar Jay Ritter and Ph.D. student Minmo Gahng contribute to this story about the roughly 25 SPACs (special purpose acquisition companies) have concerns about their financial future, according to the Wall Street Journal. Read more
This SPAC is merging with an already-public company as sponsors get creative before time runs out
SPACs are known to be a roundabout investment vehicle to take private companies public. Not this one. Bull Horn Holdings is merging with biotech Coeptis Therapeutics, a public company traded over the counter. It remains to be seen if other sponsors would replicate
IPOs are dead, and that’s bad news for the secondary market in private shares
A stagnant IPO market means there is less investor appetite for shares in private companies, which is a problem for the companies that trade those shares. Cordell Eminent Scholar Jay Ritter shares his insights for this Observer story.
SPACs Are Warning They May Go Bust
Research insights from Cordell Eminent Scholar Jay Ritter and Ph.D. student Minmo Gahng inform this story about the more than two dozen companies that say they may not survive much longer. Read more in this story from the Wall Street
Page: